Newscrate logo

Browse the latest pfizer news online for free

Search results for "pfizer"

Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings
Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings

Valneva SE (NASDAQ:VALN) shared final immunogenicity and safety data on Wednesday from the Phase 2 study, VLA15-221, of the Lyme disease vaccine candidate, VLA15.Lyme disease is a bacterial infection transmitted to humans by infected ticks, often presenting with an early “bull’s-eye” rash and flu... Read more

Benzinga - Nov 26
Europe Subcutaneous Immunoglobulin Market Growing Trends and Demands Analysis Forecast 2025 to 2034 | Pfizer Inc., Kedrion S.p.A, Biotest AG
Europe Subcutaneous Immunoglobulin Market Growing Trends and Demands Analysis Forecast 2025 to 2034 | Pfizer Inc., Kedrion S.p.A, Biotest AG

Market Size and Share:Europe Subcutaneous Immunoglobulin Market is currently valued at USD 2.5 Billion in 2024 and is anticipated to generate an estimated revenue of USD 5.9 Billion by 2034, according to the latest study by Polaris Market Research. Besides, Read more

Openpr.com - Nov 18
Advisors Capital Management LLC Acquires 621,654 Shares of Pfizer Inc. $PFE
Advisors Capital Management LLC Acquires 621,654 Shares of Pfizer Inc. $PFE

Advisors Capital Management LLC boosted its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 40.7% during the 2nd quarter, Holdings Channel.com reports. The fund owned 2,150,721 shares of the biopharmaceutical company’s stock after purchasing an additional 621,654 shares during the quarter. Ad... Read more

Americanbankingnews - Nov 14
Placebo Drug Market Set To Explode Opportunities, Future Scope 2025-2032| Pfizer, Merck, Roche, and Johnson & Johnson
Placebo Drug Market Set To Explode Opportunities, Future Scope 2025-2032| Pfizer, Merck, Roche, and Johnson & Johnson

Coherent Market Insights has released a report titled "Placebo Drug Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distributi... Read more

Openpr.com - Nov 13
Fatty Acid Oxidation Disorder Drugs Market is expected to reach US$ 13.99 billion by 2029 | Top Companies - Pfizer Inc., Action Labs, Lonza Group Ltd.
Fatty Acid Oxidation Disorder Drugs Market is expected to reach US$ 13.99 billion by 2029 | Top Companies - Pfizer Inc., Action Labs, Lonza Group Ltd.

Market Size and Growth:The Global Fatty Acid Oxidation Disorder Drugs Market Size reached US$ 9.55 billion in 2024 and is expected to reach US$ 13.99 billion by 2029, growing with a CAGR of 8.1% during the forecast period 2024-2029. The Read more

Openpr.com - Nov 10
Breakthrough Therapy Designation Market Set to Witness Massive Growth by 2032, Driven by Key Players like Pfizer, Novartis, and Roche
Breakthrough Therapy Designation Market Set to Witness Massive Growth by 2032, Driven by Key Players like Pfizer, Novartis, and Roche

Coherent Market Insights has released a report titled "Breakthrough Therapy Designation Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, g... Read more

Openpr.com - Nov 10
United States Obesity Therapeutics Market Growth Analysis 2025 | Pfizer acquired Metsera and clinched a $10 billion deal
United States Obesity Therapeutics Market Growth Analysis 2025 | Pfizer acquired Metsera and clinched a $10 billion deal

global obesity therapeutics market size reached US$ 9.19 Billion in 2023 with a rise of US$ 11.03 Billion in 2024 and is expected to reach US$ 63.75 Billion by 2033, growing at a CAGR of 21.6% during the forecast period Read more

Openpr.com - Nov 10
Herpes Zoster Oticus Market is expected to reach US$ 36.9 million by 2032 | Major key players - GSK plc., Pfizer Inc., Apotex Inc.
Herpes Zoster Oticus Market is expected to reach US$ 36.9 million by 2032 | Major key players - GSK plc., Pfizer Inc., Apotex Inc.

Market Size and Growth:The Global Herpes Zoster Oticus Market Size reached US$ 12.3 million in 2024 and is expected to reach US$ 36.9 million by 2032, growing at a CAGR of 13.2% during the forecast period 2024-2032. The Market is Read more

Openpr.com - Nov 10
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war against Novo Nordisk. Metsera, based... Read more

12news - Nov 08